- Home
- CNM vs QGEN Comparison
CNM vs QGEN Comparison
Compare CNM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- QGEN
- Stock Information
- Founded
- CNM 1996
- QGEN 1986
- Country
- CNM United States
- QGEN Netherlands
- Employees
- CNM N/A
- QGEN N/A
- Industry
- CNM Durable Goods
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNM Consumer Discretionary
- QGEN Health Care
- Exchange
- CNM Nasdaq
- QGEN Nasdaq
- Market Cap
- CNM 9.9B
- QGEN 10.7B
- IPO Year
- CNM 2021
- QGEN 1996
- Fundamental
- Price
- CNM $51.32
- QGEN $44.04
- Analyst Decision
- CNM Buy
- QGEN Buy
- Analyst Count
- CNM 11
- QGEN 7
- Target Price
- CNM $60.64
- QGEN $50.68
- AVG Volume (30 Days)
- CNM 2.0M
- QGEN 1.0M
- Earning Date
- CNM 12-02-2025
- QGEN 11-04-2025
- Dividend Yield
- CNM N/A
- QGEN 3.42%
- EPS Growth
- CNM 7.24
- QGEN 405.09
- EPS
- CNM 2.25
- QGEN 1.69
- Revenue
- CNM $7,740,000,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- CNM $4.45
- QGEN $7.37
- Revenue Next Year
- CNM $4.43
- QGEN $5.65
- P/E Ratio
- CNM $22.89
- QGEN $26.98
- Revenue Growth
- CNM 11.02
- QGEN 5.15
- 52 Week Low
- CNM $41.64
- QGEN $37.63
- 52 Week High
- CNM $67.18
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- CNM 42.04
- QGEN 30.60
- Support Level
- CNM $50.03
- QGEN $48.34
- Resistance Level
- CNM $54.02
- QGEN $49.53
- Average True Range (ATR)
- CNM 1.47
- QGEN 1.07
- MACD
- CNM 0.10
- QGEN -0.46
- Stochastic Oscillator
- CNM 23.79
- QGEN 12.32
About CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).